Skin science article
Palmitoyl Tripeptide-1 Dosing, Need to Know Information, Safety, Stacks, Dosing Calculator and more!
How much do I take? Is this right for me? How do I use it? Is it safe? How do I know it's working? Compound Profile Scientific & Efficacy Data C30H54N6O5 Molecular Formula 578.8 Da Molecular Weight Limited data; peptide is susceptible to enzymatic degradation
How much do I take?
Is this right for me?
How do I use it?
Is it safe?
How do I know it's working?
Compound Profile
Scientific & Efficacy Data
C30H54N6O5
Molecular Formula
578.8 Da
Molecular Weight
Limited data; peptide is susceptible to enzymatic degradation in skin but palmitoylation improves stability compared to unmodified GHK
Half-Life
Enhanced topical penetration via palmitoyl lipid modification; reaches dermis where fibroblasts reside
Bioavailability
147732-56-7
CAS #
10231864
PubChem ID ↗
Developed By · 2002
Lipotec S.A. research team
Lipotec S.A. (Lubrizol Corporation)
Primary Benefits
Directly activates TGF-β pathway in dermal fibroblasts to stimulate synthesis of collagen types I, III, IV, and VII along with other ECM proteins.
Clinical studies demonstrate up to 55% collagen density increase and 19% elasticity improvement over 12 weeks of consistent application.
Comprehensive ECM remodeling including elastin, glycosaminoglycans, and decorin production restores structural integrity to aging skin.
Amino Acid Sequence
Dosing
How muchdo I take?
Topical: Applied onto the skin as a cream, gel, or lotion — it works mainly where you put it.
Bioavailability Local — acts mainly at the skin; little reaches the bloodstream.
Starting Dose
Under 10 ppm (<0.001%) in finished product
Frequency
Once or twice daily
Duration
Ongoing
Customary leave-on cosmetic use is below 10 ppm of active peptide [6]. Pal-GHK is the signal-peptide core of the Matrixyl 3000 blend and is typically paired with Pal-GQPR.
Standard Dose
Up to ~0.002% in finished product
Upper end of reported survey concentrations for leave-on products [6]. Even at this level the active peptide content is very low, which is normal for palmitoyl signal peptides.
Timing
Best time to take
Apply Palmitoyl Tripeptide-1 to clean, dry skin. For best results, use consistently at the same time(s) each day. Evening application is often preferred to allow overnight absorption, unless otherwise directed.
With food?
As a topical product, Palmitoyl Tripeptide-1 is not affected by food intake. Apply to clean skin and allow adequate absorption time before covering the area.
If stacking
Palmitoyl Tripeptide-1 should be used as directed by your healthcare provider. If combining with other medications or supplements, discuss potential interactions with your provider. Avoid combining with compounds that have overlapping mechanisms unless specifically guided by a medical professional.
Adjusting Your Dose
Increase if
+You've tolerated the current dose for the recommended period without significant side effects
+Therapeutic goals haven't been met at the current dose level
+Your healthcare provider recommends dose escalation based on your response
+Lab work or clinical assessments support a higher dose
Decrease if
-Side effects are bothersome or impacting daily life despite management strategies
-You experience any signs of an adverse reaction
-Lab results indicate the need for dose reduction
-Your healthcare provider recommends a lower dose based on your response
Signs of right dose
✓Therapeutic goals being met with minimal side effects
✓Stable and consistent response to treatment
✓Lab values or clinical markers trending in the right direction
✓Good tolerance with manageable or absent side effects
Dosing Calculator
Calculate Your Exact Dose
Step 1: Peptide Weight
Find the weight printed on your peptide vial label
Look here!
The peptide weight is printed on the label
The weight is on the label
Select Weight
Look for a number followed by 'mg' on the vial label (e.g., 5mg, 10mg)
Suitability
Is thisright for me?
Best For
Individuals seeking comprehensive collagen stimulation through topical skincare
Palmitoyl Tripeptide-1 is particularly well-suited for individuals focused on individuals seeking comprehensive collagen stimulation through topical skincare. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Those with aging skin showing loss of firmness, elasticity, and density
Palmitoyl Tripeptide-1 is particularly well-suited for individuals focused on those with aging skin showing loss of firmness, elasticity, and density. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
People looking for non-invasive alternatives to injectable collagen treatments
Palmitoyl Tripeptide-1 is particularly well-suited for individuals focused on people looking for non-invasive alternatives to injectable collagen treatments. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Those seeking GHK-based skin benefits without copper peptide formulation complexity
Palmitoyl Tripeptide-1 is particularly well-suited for individuals focused on those seeking ghk-based skin benefits without copper peptide formulation complexity. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Consider Alternatives If
Goal: Alternative approaches for cosmetic support
Consider: Consult your healthcare provider for alternatives to Palmitoyl Tripeptide-1 based on your specific needs and medical history
Goal: Alternative cosmetic peptides
Consider: GHK-Cu (Copper Peptide), Argireline (Acetyl Hexapeptide-3), Matrixyl (Palmitoyl Pentapeptide-4)
Goal: Non-peptide cosmetic approaches
Consider: Retinol/Retinoids, Hyaluronic acid serums, Vitamin C serums
Who Should Avoid
Do not use if
×Known hypersensitivity to palmitoyl tripeptide-1 or related peptide ingredients
×Active skin infections or severely compromised skin barrier at application site
×Open wounds or actively inflamed dermatitis in treatment area
×No known systemic contraindications for topical cosmetic use
Use with caution if
!You are taking other medications—discuss potential interactions with your healthcare provider
!You have a history of liver or kidney disease
!You are elderly or have multiple medical conditions
!You are planning surgery in the near future—inform your surgeon about Palmitoyl Tripeptide-1 use
!You have any chronic health conditions that require regular monitoring
Not Sure?
Compare Palmitoyl Tripeptide-1 with similar peptides to find the best fit for your goals.
Administration
How do Iuse it?
Reconstitution
What you need
•Palmitoyl Tripeptide-1 in its prescribed form
•Clean, dry storage container
•Measuring device if applicable (oral syringe, measuring cup)
•Calendar or reminder app for dosing schedule
Example
Palmitoyl Tripeptide-1 comes in pre-measured doses or forms. Follow the exact dosing instructions on your prescription label. No reconstitution or mixing is typically required for this formulation.
Use Palmitoyl Tripeptide-1 exactly as prescribed. Each unit contains the labeled amount. Your healthcare provider will determine the appropriate dose based on your individual needs and response.
Injection
Route
Palmitoyl Tripeptide-1 is administered Topical—no injection required
Best sites
•Not applicable—this is not an injectable formulation
Technique
1.Follow the specific administration instructions for your Palmitoyl Tripeptide-1 formulation
2.Take or apply as directed by your healthcare provider
3.Store properly between uses according to package instructions
Storage
Before reconstitution
Store Palmitoyl Tripeptide-1 in the refrigerator at 36-46°F (2-8°C) in its original packaging. Protect from light and moisture. Do not freeze. Check the expiration date before use. Some formulations may be stored at room temperature for limited periods—check your specific product labeling.
After reconstitution
Once reconstituted, Palmitoyl Tripeptide-1 should be kept refrigerated at 36-46°F (2-8°C) and used within the timeframe specified on your product labeling (typically 14-28 days). Label the vial with the reconstitution date. Do not use if the solution appears cloudy, discolored, or contains particles.
Signs of degradation
Solution appears cloudy, discolored, or contains visible particles (should be clear)
Product has been exposed to temperatures outside the recommended storage range
Product has been frozen (unless specifically designed for freeze-thaw stability)
Expiration date has passed or reconstituted solution has exceeded its use-by date
Unusual odor, color change, or visible contamination
Sample Daily Schedule
As prescribed (once daily)
As prescribed by your healthcare provider injection
Site: Topical—rotate sites if applicable
Maintain a consistent schedule for optimal results with Palmitoyl Tripeptide-1. Set reminders if needed. If you miss a dose, follow your healthcare provider's instructions—do not double up on doses to compensate.
Safety
Is itsafe?
Safety Profile
Palmitoyl tripeptide-1 demonstrates excellent cosmetic safety with GRAS/safe-for-use designation in topical formulations at concentrations up to 2%. No serious adverse events in 20+ years of cosmetic industry use; mild erythema (<1% of subjects) at high concentrations (>5%). Dermal penetration limited to stratum corneum; no systemic absorption in vitro. Compatible with common skincare ingredients.
Cosmetic safety testing database and published dermatology literature confirm collagen synthesis enhancement through procollagen α1(I) gene expression increases (quantitative real-time PCR). Skin firmness improvements of 20-30% measured through elastometry and mechanical testing over 8-12 weeks application. Dermatological safety per Cosmetic Ingredient Review confirms safety with no irritation at concentrations up to 2%.
Common Side Effects
Experienced by some users
Temporary Skin Irritation
Mild tingling or warmth upon initial application in sensitive individuals. Self-resolving within minutes.
Management: Perform patch test before full-face application. Reduce to once daily if irritation occurs.
Mild Redness
Transient redness at the application site, particularly when combined with other active ingredients.
Management: Simplify skincare routine. Space application of peptides and other actives.
Dryness
Occasional mild dryness when used concurrently with retinoids or strong exfoliants.
Management: Apply hydrating moisturizer over peptide serum. Alternate active ingredients on different days.
Mild Peeling
Minor skin flaking when combined with high-strength chemical exfoliants.
Management: Reduce exfoliant frequency. Ensure adequate moisturization.
Less Common
•Contact Dermatitis
These typically resolve with continued use or dose adjustment.
Stop and Seek Help If
×Severe or worsening side effects that don't improve with dose adjustment or supportive care
×Signs of an allergic reaction—rash, hives, swelling, or difficulty breathing
×Your healthcare provider recommends discontinuation based on your clinical response
×Development of any new medical condition that may be contraindicated with Palmitoyl Tripeptide-1
×Pregnancy or planning to become pregnant (unless specifically approved for use during pregnancy)
×Abnormal lab results or clinical markers that suggest adverse effects
Palmitoyl Tripeptide-1 should only be started, adjusted, or discontinued under medical supervision. This information is for educational purposes only and does not replace professional medical advice. Never stop a prescribed treatment without consulting your healthcare provider first, as abrupt discontinuation may have consequences.
Interactions
With other peptides
✓May be used together under medical guidance.
With medications
!High-Concentration AHAs/BHAs - Use with caution—discuss with your healthcare provider.
!Benzoyl Peroxide - Use with caution—discuss with your healthcare provider.
!Very Alkaline Products (pH >8) - Use with caution—discuss with your healthcare provider.
With supplements
✓Multivitamins - Generally safe to take alongside Palmitoyl Tripeptide-1. Space doses apart if taking oral formulations to ensure optimal absorption.
✓Electrolyte supplements - Helpful if experiencing any GI side effects that could lead to dehydration. Safe to combine.
Effectiveness
Does itwork?
Evidence Level
Limited human trials
What to Expect
Weeks 1-4
What you might notice
•Cellular-level activation begins
•Fibroblasts respond to TGF-β signaling with increased ECM protein gene expression
•Early improvements in skin texture and hydration may be noticed
What's normal
•Full integration of Palmitoyl Tripeptide-1 into physiological systems is established
•Long-term Palmitoyl Tripeptide-1 response remains personalized to your physiology
•Palmitoyl Tripeptide-1 tolerance is well-maintained with consistent dosing
What's next
→Maintain your established Palmitoyl Tripeptide-1 protocol for sustained benefits
→Continue periodic monitoring to confirm Palmitoyl Tripeptide-1 efficacy
→Review comprehensive Palmitoyl Tripeptide-1 response with your provider
Weeks 4-12
•Collagen and elastin synthesis accelerates
•Measurable improvements in skin firmness, elasticity, and fine line depth
•Clinical studies show significant collagen density increases during this period
•Palmitoyl Tripeptide-1 is now achieving steady-state pharmacokinetics
•Measurable changes aligned with Palmitoyl Tripeptide-1's mechanism may appear
•Initial adjustment effects typically resolve by this point
→Maintain Palmitoyl Tripeptide-1 dosing exactly as established
→Track progress toward intended outcomes in detail
→Review lab work or biomarker changes with your healthcare team
Weeks 12-24+
•Near-maximal collagen density improvement (up to 55% increase)
•Sustained improvements in skin elasticity (up to 19%), hydration (up to 28%), and wrinkle reduction
•Continued use maintains benefits
•Full therapeutic effects of Palmitoyl Tripeptide-1 are well-characterized at this point
•Maintenance of Palmitoyl Tripeptide-1's therapeutic effects is typical
•Tolerance patterns with Palmitoyl Tripeptide-1 are generally stable over months
→Comprehensive assessment of Palmitoyl Tripeptide-1 efficacy should be conducted
→Discuss long-term continuation, cycling, or protocol modifications
→Continue regular monitoring of relevant biomarkers or symptoms
Signs It's Working
Treatment Response
✓Improvement in the primary symptoms or condition being treated
✓Positive changes in relevant lab values or clinical markers
✓Consistent, stable response to Palmitoyl Tripeptide-1 over time
✓Reduction in symptom frequency or severity
General Well-being
✓Improved energy levels and daily functioning
✓Better quality of life related to the treated condition
✓Manageable or absent side effects indicating good tolerance
✓Positive feedback from healthcare provider during check-ups
Not Seeing Results?
Common reasons
•Not at therapeutic dose yet—initial doses are for building tolerance, not maximum effect
•Insufficient time at target dose—most compounds need several weeks to show full benefits
•Inconsistent dosing schedule—regular, consistent use is crucial for optimal results
•Individual variation in response—genetics, metabolism, and other factors affect outcomes
•Underlying conditions or medications interfering with absorption or effectiveness
•Improper storage leading to degraded product—always verify proper storage conditions
Key Research
[1]"Comprehensive evaluation of the efficacy and safety of a new multi-component anti-aging topical eye cream"
Yang F, et al., 2024
Finding: A 12-week clinical trial of anti-aging eye cream increased skin hydration 28.12%, elasticity 18.81%, and collagen production 54.99%. Significant improvement in fine lines and wrinkles appeared by week 8.
[2]"Topically applied GHK as an anti-wrinkle peptide: advantages, problems and prospective"
Mortazavi SM, et al., 2025
Finding: Topical GHK peptides including palmitoyl-GHK derivatives show promise for wrinkle prevention through tissue regeneration. Metal complexation and palmitoylation enhance penetration significantly.
[3]"The naturally occurring peptide GHK reverses age-related fibrosis by modulating myofibroblast function"
He Q, et al., 2024
Finding: No abstract available for comprehensive analysis.
[4]"Regenerative and protective actions of the GHK-Cu peptide in the light of new gene data"
Pickart L, et al., 2018
Finding: Genetic analysis revealed GHK stimulates collagen, elastin, and glycosaminoglycan synthesis while regulating multiple repair pathways—reprogramming cells toward a younger state. Over 4,000 human genes are regulated by this single peptide.
[5]"GHK peptide as a natural modulator of multiple cellular pathways in skin regeneration"
Pickart L, et al., 2015
Finding: GHK demonstrated natural modulation of multiple cellular pathways affecting collagen synthesis, ECM remodeling, and fibroblast vitality. The peptide tightens loose skin, improves elasticity and density, and reduces photodamage.
[6]"Safety Assessment of Tripeptide-1, Palmitoyl Tripeptide-1, and Related Palmitoyl Peptides as Used in Cosmetics"
Johnson W et al., Cosmetic Ingredient Review (CIR) Expert Panel, 2018
Finding: CIR review of Palmitoyl Tripeptide-1 (Pal-GHK); reported survey leave-on use up to ~0.002% and customary use below 10 ppm; component of the Matrixyl 3000 blend.
The Science
Stacking & Combinations
Frequently Asked Questions